Objective To investigate the curative effect and nursing plan for carbazochrome sodium sulfonate in pediatric abdominal op-eration hemostasis. Methods 86 cases of patients with abdominal surgery were randomly divided into the control group and the treat-ment group, 43 cases in each group. Two groups were treated by routine treatment, the treatment group used carbazochrome sodium sul-fonate ( Preoperative 30 min plus 0. 9% sodium chloride infusion ) , and intravenous drip 2 times/d, medication for 2 d. The control group used Phenloildine ( Preoperative 30min plus 0. 9% sodium chloride infusion ) , and intravenous drip 2 times/d, medication for 2 days. According to the postoperative pain, the children were given analgesics, and the perioperative period for children to develop targeted and personalized care programs. To observe and bleeding time, bleeding volume, bleeding volume, wild case and postoperative drainage rate of the children. The children were recorded before and after the operation of 24 h, blood routine, blood coagulation function of liver function and adverse reactions. Results Compared with the control group, the amount of bleeding ( P ﹤ 0. 05 ) , bleeding volume per unit area and volume of drainage in the patients were less than those of the control group ( P ﹤ 0. 05 ) . The treatment group with the wild resolution compared with the control group ( P ﹤ 0. 05 ) , The clinical effect of treatment group was significantly ( P ﹤ 0. 05 );Two groups of patients after 24h, blood coagulation index, the level of liver function index and preoperative no difference ( P ﹥ 0. 05 ) , and there was no difference between the control group and the treatment group ( P ﹥ 0. 05 ) , No obvious adverse reactions. Conclusion Carbazochrome sodium sulfonate on pediatric abdominal surgery to stop bleeding effect is remarkable, effectively shorten the bleeding time, decrease the wound bleeding amount, unit area hemorrhage volume has postoperative drainage, improve the operative field definition and good safety, will not affect the function of coagulation formation postoperative thromboembolic, no obvious adverse reactions.%目的：探讨卡络磺钠用于小儿腹部手术止血的疗效及护理方案。方法将收治的86例需腹部手术患儿随机分为对照组和治疗组，各43例。两组均进行常规治疗，治疗组加用卡络磺钠注射液，对照组加用酚磺乙胺，均于术前30 min加入0.9%氯化钠注射液静脉滴注，术后静脉滴注2次/日，用药2 d。术后疼痛较剧烈患儿给予镇痛药。观察并记录患儿术中出血时间、切口出血量、单位面积出血量、术野情况以及术后引流量；记录患儿术前及术后24 h凝血功能情况、血常规、肝功能情况及不良反应发生情况。结果与对照组比较，治疗组术中平均出血时间短于对照组（ P ﹤0.05），且患儿切口出血量、单位面积出血量及术后引流量均少于对照组（ P ﹤0.05），治疗组术野清晰度较对照组更优( P ﹤0.05)，治疗组临床疗效显著( P ﹤0.05)；两组患儿术后24 h凝血功能指标、血常规水平、肝功能指标与术前无明显差异（ P ﹥0.05），且两组间无明显差异（ P ﹥0.05），未见明显不良反应。结论卡络磺钠可对小儿腹部手术起到良好止血效果，有效缩短术中出血时间，减少切口出血量、单位面积出血量以及术后引流量，提高术野的清晰度，且安全性良好，不会影响机体凝血功能，无明显不良反应。护理人员应加强患儿心理护理，加强与患儿家属沟通，注重细节，减轻患儿痛苦。
展开▼
